Have you been diagnosed with large B-cell lymphoma (LBCL) and have not yet received treament? If so, you may be able to take part in a research study looking at the efficacy of giving a drug called glofitamab in combination with other drugs. The drugs are: polatuzumab vedotin (Pola) (also known as Polivy→) and rituximab (R) (also known as Rituxan→ and MabThera→), as well as a group of chemotherapy drugs, cyclophosphamide (C), doxorubicin (H), and prednisone (P) (referred to as Pola-R-CHP).

What factors influence how the brain takes in sugar to use it as energy? If you are between the ages of 18-45 years old and are healthy and of normal weight, you might be eligible to participate in this study to help us understand how the way sugar enters the body affects how sugar enters the brain.

Do you want to know more about your calf muscles? Do you get tired easily? You may be able to participate in a research study to find out the effect of your calf muscle length on your muscle activity and fatigue.

Focus groups for adolescents and caregivers who have had eating disorders or disordered eating to help us develop a new treatment that is appropriate for members of the Latinx community.

In this study, we will look at how clinics give care to patients of all body sizes. We will talk to doctors and clinic staff to find out their policies and how they provide care that includes everyone.

Collect Biospecimens from subjects who are newly diagnosed with Acute Myeloid Leukemia (AML)

This is a clinical research study to learn more about a drug being developed to treat Hidradenitis Suppurativa. We want to learn more about how this study drug affects those with Hidradenitis Suppurativa.

In this study, we want to learn how underrepresented soldiers stay resilient, fit, and healthy.

The goal of this study is to gather more information on the experiences of LGBTQ+ individuals during the family planning process, specifically as they relate to elements of stress and social support. This study will include any LGBTQ+ individuals who have gone through any part of the family planning process, as well as people who work with LGBTQ+ individuals, including (but not limited to) doctors, doulas, lactation consultants, and legal professionals. This will provide groundwork to guide questions in future research on parent and child health in LGBTQ+ populations.

The purpose of this study is to find out whether the addition of HDV to Humalog® will improve diabetes control by reducing high blood sugar after meals and/or reducing the risk of low blood sugar (hypoglycemia) during insulin treatment. The safety and tolerability of Humalog® with or without added HDV will also be evaluated. The study drugs will be administered by subcutaneous (under the skin) injection.